English
Insider transactions
EDGARFulcrum Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 6 transactions, 417,562 shares
- Sum of shares × price per share: 1,485,742.64
- Open-market sales (code S)
- 8 transactions, 4,241,591 shares
- Sum of shares × price per share: 58,989,269.76
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–27 of 27
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 Filed 2026-07-20 | TANG KEVIN 10% ownerTANG CAPITAL MANAGEMENT LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 50,945 | 3.52 | 179,326.4Derived: shares × price per share. Exact value 179326.40. | 7,080,945 | Indirect (I) See Footnote | No | F3, F2
| Open filing 0001178579-26-000016 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-20 | TANG KEVIN 10% ownerTANG CAPITAL MANAGEMENT LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 116,671 | 3.56 | 415,348.76Derived: shares × price per share. Exact value 415348.76. | 7,030,000 | Indirect (I) See Footnote | No | F1, F2
| Open filing 0001178579-26-000016 Read from the filing’s XML Dispute this row |
| 2026-07-15 Filed 2026-07-15 | TANG KEVIN 10% ownerTANG CAPITAL MANAGEMENT LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 107,377 | 3.56 | 382,262.12Derived: shares × price per share. Exact value 382262.12. | 6,913,329 | Indirect (I) See Footnote | No | F5, F2
| Open filing 0001178579-26-000014 Read from the filing’s XML Dispute this row |
| 2026-07-14 Filed 2026-07-15 | TANG KEVIN 10% ownerTANG CAPITAL MANAGEMENT LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 53,651 | 3.56 | 190,997.56Derived: shares × price per share. Exact value 190997.56. | 6,730,000 | Indirect (I) See Footnote | No | F3, F2
| Open filing 0001178579-26-000014 Read from the filing’s XML Dispute this row |
| 2026-07-14 Filed 2026-07-15 | TANG KEVIN 10% ownerTANG CAPITAL MANAGEMENT LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 75,952 | 3.58 | 271,908.16Derived: shares × price per share. Exact value 271908.16. | 6,805,952 | Indirect (I) See Footnote | No | F4, F2
| Open filing 0001178579-26-000014 Read from the filing’s XML Dispute this row |
| 2026-07-13 Filed 2026-07-15 | TANG KEVIN 10% ownerTANG CAPITAL MANAGEMENT LLC 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 12,966 | 3.54 | 45,899.64Derived: shares × price per share. Exact value 45899.64. | 6,676,349 | Indirect (I) See Footnote | No | F1, F2
| Open filing 0001178579-26-000014 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Hill Colin Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294683 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Ezekowitz Alan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294680 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | GERAGHTY JAMES A Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294690 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | King Rachel K. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294691 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Dorton Katina Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294699 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Gould Robert J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294697 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Banks Sonja Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294703 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Haviland Kate Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 32,000 | Direct (D) | No | F1
| Open filing 0001193125-26-294692 Read from the filing’s XML Dispute this row |
| 2026-06-26 Filed 2026-06-30 | Ezekowitz Alan Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 18,000 | 3.6452 | 65,613.6Derived: shares × price per share. Exact value 65613.6000. | 10,927 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-290622 Read from the filing’s XML Dispute this row |
| 2026-04-23 Filed 2026-05-01 | Lehrer-Graiwer Joshua Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 64,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 64,000 | Direct (D) | No | F1
| Open filing 0001193125-26-201468 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Gould Robert J Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15,000 | 10.7238 | 160,857Derived: shares × price per share. Exact value 160857.0000. | 454,864 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-037573 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Sapir Alex Director · Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 650,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 650,000 | Direct (D) | No | F1
| Open filing 0001193125-26-037572 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Tourangeau Greg Officer: Principal Accounting Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 57,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 57,000 | Direct (D) | No | F1
| Open filing 0001193125-26-037575 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Oltmans Curtis Gale Officer: Chief Legal Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 170,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 170,000 | Direct (D) | No | F1
| Open filing 0001193125-26-037576 Read from the filing’s XML Dispute this row |
| 2026-02-02 Filed 2026-02-04 | Musso Alan A Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 170,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 170,000 | Direct (D) | No | F1
| Open filing 0001193125-26-037574 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-02-04 | Gould Robert J Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15,000 | 10.8726 | 163,089Derived: shares × price per share. Exact value 163089.0000. | 469,864 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-037606 Read from the filing’s XML Dispute this row |
| 2026-01-02 Filed 2026-01-06 | Gould Robert J Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15,000 | 11.8726 | 178,089Derived: shares × price per share. Exact value 178089.0000. | 469,864 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-004572 Read from the filing’s XML Dispute this row |
| 2025-12-15 Filed 2025-12-17 | Oltmans Curtis Gale Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,452 | 12.92 | 44,599.84Derived: shares × price per share. Exact value 44599.84. | 10,252 | Direct (D) | No | F1, F2
| Open filing 0001193125-25-322740 Read from the filing’s XML Dispute this row |
| 2025-12-08 Filed 2025-12-10 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,377,020 | 13.33 | 18,355,676.6Derived: shares × price per share. Exact value 18355676.60. | 8,852,079 | Indirect (I) See footnotes | No | F1, F2, F3
| Open filing 0001231919-25-000596 Read from the filing’s XML Dispute this row |
| 2025-12-08 Filed 2025-12-10 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,706,397 | 14.28 | 38,647,349.16Derived: shares × price per share. Exact value 38647349.16. | 6,145,682 | Indirect (I) See footnotes | No | F4, F2, F3
| Open filing 0001231919-25-000596 Read from the filing’s XML Dispute this row |
| 2025-12-08 Filed 2025-12-10 | RA CAPITAL MANAGEMENT, L.P. 10% ownerRA Capital Healthcare Fund LP 10% ownerKolchinsky Peter 10% ownerShah Rajeev M. 10% owner | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 91,722 | 14.98 | 1,373,995.56Derived: shares × price per share. Exact value 1373995.56. | 6,053,960 | Indirect (I) See footnotes | No | F5, F2, F3
| Open filing 0001231919-25-000596 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC Common Stock | 8.9 | 6,803,785 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-26-000588 Dispute this row |
| Oleg Nodelman Common Stock | 8.9 | 6,803,785 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-26-000588 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 8.2 | 6,297,538 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0000935836-26-000588 Dispute this row |
| ADAR1 Capital Management, LLC Common Stock, par value $0.001 per share | 8.7 | 6,648,027.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001104659-26-128728 Dispute this row |
| Daniel Schneeberger Common Stock, par value $0.001 per share | 8.7 | 6,648,027.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001104659-26-128728 Dispute this row |
| Nantahala Capital Management, LLC Common stock, par value $0.001 per share | 8.62 | 6,575,352.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127211 Dispute this row |
| Wilmot B. Harkey Common stock, par value $0.001 per share | 8.62 | 6,575,352.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127211 Dispute this row |
| Daniel Mack Common stock, par value $0.001 per share | 8.62 | 6,575,352.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-127211 Dispute this row |
| Montanova Capital, LLC Common Stock, par value $0.001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-007765 Dispute this row |
| Averill Master Fund, Ltd. Common Stock, par value $0.001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-007765 Dispute this row |
| Aaron Cowen Common Stock, par value $0.001 per share | 0 | 0.00 | 09/30/2026 Filed 2026-11-13 | SCHEDULE 13G/AAmendment 3 | Open filing 0000919574-26-007765 Dispute this row |
| BANK OF AMERICA CORP /DE/ Common Stock | 1.5 | 1,114,867.00 | 09/30/2026 Filed 2026-10-28 | SCHEDULE 13G/AAmendment 1 | Open filing 0000070858-26-000532 Dispute this row |
| BlackRock Portfolio Management LLC Common Stock | 8.1 | 6,155,437 | 09/30/2026 Filed 2026-10-27 | SCHEDULE 13G/AAmendment 1 | Open filing 0002052113-26-001118 Dispute this row |
| TANG CAPITAL MANAGEMENT, LLC Common stock, par value $0.001 per share | 10.4 | 6,913,329.00 | 07/13/2026 Filed 2026-07-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-008613 Dispute this row |
| KEVIN TANG Common stock, par value $0.001 per share | 10.4 | 6,913,329.00 | 07/13/2026 Filed 2026-07-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-008613 Dispute this row |
| TANG CAPITAL PARTNERS, LP Common stock, par value $0.001 per share | 2.5 | 1,630,142.00 | 07/13/2026 Filed 2026-07-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-008613 Dispute this row |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP Common stock, par value $0.001 per share | 3.2 | 2,160,423.00 | 07/13/2026 Filed 2026-07-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-008613 Dispute this row |
| TANG CAPITAL PARTNERS III, INC Common stock, par value $0.001 per share | 2.5 | 1,630,127.00 | 07/13/2026 Filed 2026-07-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-008613 Dispute this row |
| TANG CAPITAL PARTNERS IV, INC Common stock, par value $0.001 per share | 2.2 | 1,492,637.00 | 07/13/2026 Filed 2026-07-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-26-008613 Dispute this row |
| TCG Crossover GP II, LLC Common Stock, par value $0.001 per share | 0 | 0 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-352345 Dispute this row |
| TCG Crossover Fund II, L.P. Common Stock, par value $0.001 per share | 0 | 0 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-352345 Dispute this row |
| Chen Yu Common Stock, par value $0.001 per share | 0 | 0 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0001193125-26-352345 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.001 par value per share | 0.0 | 0.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 7 | Open filing 0001231919-26-000923 Dispute this row |
| Peter Kolchinsky Common Stock, $0.001 par value per share | 0.0 | 0.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 7 | Open filing 0001231919-26-000923 Dispute this row |
| Rajeev Shah Common Stock, $0.001 par value per share | 0.0 | 0.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 7 | Open filing 0001231919-26-000923 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.001 par value per share | 0.0 | 0.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 7 | Open filing 0001231919-26-000923 Dispute this row |
| Nantahala Capital Management, LLC Common stock, par value $0.001 per share | 8.22 | 5,475,040.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001104659-26-097278 Dispute this row |
| Wilmot B. Harkey Common stock, par value $0.001 per share | 8.22 | 5,475,040.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001104659-26-097278 Dispute this row |
| Daniel Mack Common stock, par value $0.001 per share | 8.22 | 5,475,040.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G | Open filing 0001104659-26-097278 Dispute this row |
| Montanova Capital, LLC Common Stock, par value $0.001 per share | 5.5 | 3,680,921.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-005528 Dispute this row |
| Averill Master Fund, Ltd. Common Stock, par value $0.001 per share | 3.8 | 2,553,201.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-005528 Dispute this row |
| Aaron Cowen Common Stock, par value $0.001 per share | 5.5 | 3,680,921.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-005528 Dispute this row |
| BANK OF AMERICA CORP /DE/ Common Stock | 6.7 | 4,468,123.00 | 06/30/2026 Filed 2026-08-03 | SCHEDULE 13G | Open filing 0000070858-26-000396 Dispute this row |
| BlackRock, Inc. Common Stock | 7.2 | 4,802,880 | 06/30/2026 Filed 2026-07-28 | SCHEDULE 13G/AAmendment 4 | Open filing 0002012383-26-002576 Dispute this row |
| BlackRock Portfolio Management LLC Common Stock | 6.0 | 4,021,379 | 06/30/2026 Filed 2026-07-17 | SCHEDULE 13G | Open filing 0002052113-26-000745 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 9.0 | 6,000,000.00 | 06/17/2026 Filed 2026-06-25 | SCHEDULE 13G | Open filing 0000935836-26-000330 Dispute this row |
| Oleg Nodelman Common Stock | 9.0 | 6,000,000.00 | 06/17/2026 Filed 2026-06-25 | SCHEDULE 13G | Open filing 0000935836-26-000330 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 8.4 | 5,614,199.00 | 06/17/2026 Filed 2026-06-25 | SCHEDULE 13G | Open filing 0000935836-26-000330 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 9.0 | 6,000,000.00 | 06/17/2026 Filed 2026-06-25 | SCHEDULE 13G | Open filing 0000935836-26-000331 Dispute this row |
| Oleg Nodelman Common Stock | 9.0 | 6,000,000.00 | 06/17/2026 Filed 2026-06-25 | SCHEDULE 13G | Open filing 0000935836-26-000331 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 8.4 | 5,614,199.00 | 06/17/2026 Filed 2026-06-25 | SCHEDULE 13G | Open filing 0000935836-26-000331 Dispute this row |
| TANG CAPITAL MANAGEMENT, LLC Common stock, par value $0.001 per share | 8.2 | 5,451,800.00 | 06/03/2026 Filed 2026-06-10 | SCHEDULE 13G | Open filing 0001214659-26-007338 Dispute this row |
| KEVIN TANG Common stock, par value $0.001 per share | 8.2 | 5,451,800.00 | 06/03/2026 Filed 2026-06-10 | SCHEDULE 13G | Open filing 0001214659-26-007338 Dispute this row |
| TANG CAPITAL PARTNERS, LP Common stock, par value $0.001 per share | 1.9 | 1,249,373.00 | 06/03/2026 Filed 2026-06-10 | SCHEDULE 13G | Open filing 0001214659-26-007338 Dispute this row |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP Common stock, par value $0.001 per share | 2.5 | 1,703,690.00 | 06/03/2026 Filed 2026-06-10 | SCHEDULE 13G | Open filing 0001214659-26-007338 Dispute this row |
| TANG CAPITAL PARTNERS III, INC Common stock, par value $0.001 per share | 1.9 | 1,249,367.00 | 06/03/2026 Filed 2026-06-10 | SCHEDULE 13G | Open filing 0001214659-26-007338 Dispute this row |
| TANG CAPITAL PARTNERS IV, INC Common stock, par value $0.001 per share | 1.9 | 1,249,370.00 | 06/03/2026 Filed 2026-06-10 | SCHEDULE 13G | Open filing 0001214659-26-007338 Dispute this row |
| Nantahala Capital Management, LLC Common stock, par value $0.001 per share | 4.58 | 3,050,040.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-062675 Dispute this row |
| Wilmot B. Harkey Common stock, par value $0.001 per share | 4.58 | 3,050,040.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-062675 Dispute this row |
| Daniel Mack Common stock, par value $0.001 per share | 4.58 | 3,050,040.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-062675 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,638,030 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 55,117 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.